Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Pharmacology and Therapeutics

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PHARMTHERA.2006.04.009PMID 16766035
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

  2007cited by this paper
• Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex

  2007cited by this paper
• The ATP-binding Cassette Transporter ABCG2 (BCRP), a Marker for Side Population Stem Cells, Is Expressed in Human Heart

  2006cited by this paper
• Impact of ABCB1 (MDR1) haplotypes on tacrolimus dosing in adult lung transplant patients who are CYP3A5 *3/*3 non-expressors.

  2006cited by this paper
• Genetic basis of toxic reactions to drugs and chemicals.

  2006cited by this paper
• Role of ABCG2/BCRP in biology and medicine.

  2006cited by this paper
• Multidrug resistance‐1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia

  2006cited by this paper
• Vascular colocalization of P‐glycoprotein, multidrug‐resistance associated protein 1, breast cancer resistance protein and major vault protein in human epileptogenic pathologies

  2006cited by this paper
• ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.

  2006cited by this paper
• EPIDERMAL GROWTH FACTOR-MEDIATED ACTIVATION OF THE MAP KINASE CASCADE RESULTS IN ALTERED EXPRESSION AND FUNCTION OF ABCG2 (BCRP)

  2006cited by this paper
• MDR1 Genetic Polymorphisms and Comparison of MDR1 Haplotype Profiles in Korean and Vietnamese Populations

  2005cited by this paper
• A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection.

  2005cited by this paper
• NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

  2005cited by this paper
• VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION

  2005cited by this paper
• Polymorphisms of MRP1 (ABCC1) and related ATP-dependent drug transporters.

  2005cited by this paper
• High-speed screening of human ATP-binding cassette transporter function and genetic polymorphisms: new strategies in pharmacogenomics.

  2005cited by this paper
• Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.

  2005cited by this paper
• ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.

  2005cited by this paper
• LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE

  2005cited by this paper
• Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment

  2005cited by this paper
• Pharmacogenetics-based therapeutic recommendations — ready for clinical practice?

  2005cited by this paper
• Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability

  2005cited by this paper
• Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance‐Associated Protein 2

  2005cited by this paper
• Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport

  2005cited by this paper
• Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation

  2005cited by this paper
• Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications

  2005cited by this paper
• Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.

  2005cited by this paper
• Sirolimus and Tacrolimus Trough Concentrations and Dose Requirements after Kidney Transplantation in Relation to CYP3A5 and MDR1 Polymorphisms and Steroids

  2005cited by this paper
• Daily Rhythms of P‐glycoprotein Expression in Mice

  2005cited by this paper
• Single nucleotide polymorphisms modify the transporter activity of ABCG2

  2005cited by this paper
• FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA

  2005cited by this paper
• Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.

  2005cited by this paper
• Transporters and drug therapy: Implications for drug disposition and disease

  2005cited by this paper
• GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia

  2005cited by this paper
• Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo

  2005cited by this paper
• MDR1 genotype-related pharmacokinetics: fact or fiction?

  2005cited by this paper
• A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination

  2005cited by this paper
• Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia.

  2005cited by this paper
• Functional characterization of non-synonymous single nucleotide polymorphisms in the gene encoding human multidrug resistance protein 1 (MRP1/ABCC1)

  2005cited by this paper
• Effect of ABCG2 genotype on the oral vioavailability of topotecan

  2005cited by this paper
• Clinical aspects of the MDR1 (ABCB1) gene polymorphism.

  2004cited by this paper
• Intracellular and Plasma Pharmacokinetics of Nelfinavir and M8 in HIV-Infected Patients: Relationship with P-Glycoprotein Expression

  2004cited by this paper
• Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution

  2004cited by this paper
• Tacrolimus Dosing in Adult Lung Transplant Patients Is Related to Cytochrome P4503A5 Gene Polymorphism

  2004cited by this paper
• Linkage Disequilibrium and Haplotype Architecture for two ABC Transporter Genes (ABCC1 and ABCG2) in Chinese Population: Implications for Pharmacogenomic Association Studies

  2004cited by this paper
• The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients.

  2004cited by this paper
• CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects

  2004cited by this paper
• Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy

  2004cited by this paper
• Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1).

  2004cited by this paper
• The drug efflux pump MRP2: Regulation of expression in physiopathological situations and by endogenous and exogenous compounds

  2004cited by this paper
• Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis

  2004cited by this paper
• Expression of multidrug transporters in dysembryoplastic neuroepithelial tumors causing intractable epilepsy.

  2004cited by this paper
• Carbamazepine regulates intestinal P‐glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans

  2004cited by this paper
• MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment.

  2004cited by this paper
• Importance of P-glycoprotein at blood-tissue barriers.

  2004cited by this paper
• Drug interactions with St John's wort : mechanisms and clinical implications.

  2004cited by this paper
• MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.

  2004cited by this paper
• Cytochrome P450 3A4 and P‐glycoprotein Expression in Human Small Intestinal Enterocytes and Hepatocytes: A Comparative Analysis in Paired Tissue Specimens

  2004cited by this paper
• CYP3A5 and MDR1 Genetic Polymorphisms and Cyclosporine Pharmacokinetics After Renal Transplantation

  2004cited by this paper
• Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution

  2004cited by this paper
• ABCG2 – a transporter for all seasons

  2004cited by this paper
• Characterization of the Cellular Localization, Expression Level, and Function of SNP Variants of MRP2/ABCC2

  2004cited by this paper
• Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2

  2004cited by this paper
• Functional Correlation of P-Glycoprotein Expression and Genotype with Expression of the Human Immunodeficiency Virus Type 1 Coreceptor CXCR4

  2004cited by this paper
• Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype

  2004cited by this paper
• Functional Analysis of SNPs Variants of BCRP/ABCG2

  2004cited by this paper
• Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms.

  2004cited by this paper
• Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects.

  2004cited by this paper
• Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.

  2004cited by this paper
• P-glycoprotein function in the elderly

  2004cited by this paper
• Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia

  2004cited by this paper
• MDR-1 C3435T Polymorphism Influences Cyclosporine A Dose Requirement in Liver-Transplant Recipients

  2004cited by this paper
• Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice.

  2004cited by this paper
• The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant Patients

  2003cited by this paper
• Regulation of Drug and Bile Salt Transporters in Liver and Intestine

  2003cited by this paper
• MDR1 Ala893 polymorphism is associated with inflammatory bowel disease.

  2003cited by this paper
• Digoxin pharmacokinetics and MDR1 genetic polymorphisms

  2003cited by this paper
• MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes

  2003cited by this paper
• Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

  2003cited by this paper
• Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR‐1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

  2003cited by this paper
• Frequency of MRP1 genetic polymorphisms and their functional significance in Caucasians: detection of a novel mutation G816A in the human MRP1 gene

  2003cited by this paper
• MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients

  2003cited by this paper
• Homozygous mutation Arg768Trp in the ABC-transporter encoding gene MRP2/cMOAT/ABCC2 causes Dubin-Johnson syndrome in a Caucasian patient

  2003cited by this paper
• Cyclosporine a augments P-glycoprotein expression in the regenerating rat liver.

  2003cited by this paper
• Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

  2003cited by this paper
• ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation.

  2003cited by this paper
• Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

  2003cited by this paper
• ABC of oral bioavailability: transporters as gatekeepers in the gut

  2003cited by this paper
• Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations.

  2003cited by this paper
• Effects of continuous exposure to digoxin on MDR1 function and expression in Caco‐2 cells

  2003cited by this paper
• Genetic polymorphism at the 5' regulatory region of multidrug resistance 1 (MDR1) and its association with interindividual variation of expression level in the colon.

  2003cited by this paper
• Efflux transporters of the human placenta.

  2003cited by this paper
• 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.

  2003cited by this paper
• A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2).

  2003cited by this paper
• Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients.

  2003cited by this paper
• MDR1 Haplotypes Do Not Affect the Steady‐State Pharmacokinetics of Cyclosporine in Renal Transplant Patients

  2003cited by this paper
• Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer.

  2003cited by this paper
• MDR1 Genotype-Related Duodenal Absorption Rate of Digoxin in Healthy Japanese Subjects

  2003cited by this paper
• Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein

  2002cited by this paper
• The effects of the human MDR1 genotype on the expression of duodenal P‐glycoprotein and disposition of the probe drug talinolol

  2002cited by this paper

• Effect of ABCG2 genetic polymorphisms on the transport of anti-seizure medications in hCMEC/D3 cell lines

  2026cites this paper
• Genetic determinants of efficacy of antiviral drugs revealed by genome-wide CRISPR screens.

  2025cites this paper
• Achieving effective and safe pharmacotherapy in pediatric severe traumatic brain injury: a conceptual framework

  2025cites this paper
• Constant Temperature Electrochemical Biosensor for SNP Detection in Human Genomic DNA Based on DNA Melting Analysis

  2025cites this paper
• Novel enabling strategies for oral peptide delivery.

  2025cites this paper
• Genetic resistance to vector-borne hemoprotozoa in livestock: molecular markers, host-parasite interactions, and implications for breeding and control

  2025cites this paper
• Potential Molecular Markers for Cholecystic Inflammation-Induced Carcinogenesis Based on RNA-Seq Gene Screening.

  2024cites this paper
• Wogonin effects on the efflux transporters BCRP and MRP2, explain its effectiveness in ulcerative colitis: implications for metabolic and transport interactions.

  2024cites this paper
• PROTAC-attractive site as a new target for suppressing P-glycoprotein activity.

  2024cites this paper
• The role of drug efflux and uptake transporters in the plasma pharmacokinetics and tissue disposition of morphine and its main metabolites.

  2024cites this paper
• Brightening the Path: Riboflavin Illuminates Breast Cancer Resistance Protein Monitoring

  2024cites this paper
• Recent advances on the application of nanobiomimetic structures as drug delivery systems

  2024cites this paper
• Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy.

  2024cites this paper
• Bleeding Events Associated with Rivaroxaban Therapy in Naive Patients with Nonvalvular Atrial Fibrillation: A Longitudinal Study from a Genetic Perspective with INR Follow-Up

  2024cites this paper
• Studying the association between some genetic polymorphisms and Doxorubicin-Induced Cardiotoxicity

  2024cites this paper
• Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2.

  2023cites this paper
• Insights into Intestinal P-glycoprotein Function using Talinolol: A PBPK Modeling Approach

  2023cites this paper
• Ivermectin Toxicokinetics in Rainbow Trout (Oncorhynchus mykiss) following P-glycoprotein Induction

  2023cites this paper
• Machine Learning Techniques Applied to the Study of Drug Transporters

  2023cites this paper
• A study integrated metabolomics and network pharmacology to investigate the effects of Shicao in alleviating acute liver injury.

  2023cites this paper
• The Impact of Polymorphisms in ATP-Binding Cassette Transporter Genes on Anthracycline-Induced Early Cardiotoxicity in Patients with Breast Cancer

  2023cites this paper
• Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation

  2023cites this paper
• Targeting breast cancer resistance protein (BCRP/ABCG2) in cancer

  2023cites this paper
• Matrix stiffness triggers chemoresistance through elevated autophagy in pancreatic ductal adenocarcinoma.

  2023cites this paper
• P-glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Main Active Heroin Metabolites 6-monoacetylmorphine (6-MAM) and Morphine in Mice

  2023cites this paper
• TNF-α and IL-1β Exposure Modulates the Expression and Functionality of P-Glycoprotein in Intestinal and Renal Barriers.

  2022cites this paper
• Characterization of Clofazimine as a Potential Substrate of Drug Transporter

  2022cites this paper
• Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression

  2022cites this paper
• CRISPR/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme.

  2022cites this paper
• Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity

  2022cites this paper
• Study of Allosteric Transitions of Human P-Glycoprotein by Using the Two-State Anisotropic Network Model

  2022cites this paper
• Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro

  2022cites this paper
• Determination of the frequency of ABCB1 gene polymorphisms (C1236T, C3435T) in the population of the Tashkent region of Uzbekistan

  2022influential citation
• A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors

  2022cites this paper
• Green tea polyphenols in cardiometabolic health: A critical appraisal on Phytogenomics towards personalized green tea

  2022cites this paper
• P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease

  2022cites this paper
• ATP binding cassette transporters and cancer: revisiting their controversial role.

  2021cites this paper
• Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients

  2021cites this paper
• Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis

  2021cites this paper
• Genetic basis of anthracyclines cardiotoxicity: Literature review

  2021cites this paper
• The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma

  2021cites this paper
• Bioinformatics Analysis of The Expression of ATP Binding Cassette Transporters and The Screening of Regulatory Genes in PTEN/PI3K/Akt/mTOR Signaling Pathway in The Hepatocellular Carcinoma

  2021cites this paper
• The genetic underpinnings of anthracycline‐induced cardiomyopathy predisposition

  2021cites this paper
• P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib.

  2021cites this paper
• ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?

  2021cites this paper
• In Vitro Evaluation of P-gp-Mediated Drug–Drug Interactions Using the RPTEC/TERT1 Human Renal Cell Model

  2021cites this paper
• Investigation of the 1249G>A Genetic Variation of ABCC2 Drug Transporter Gene in the Turkish Population

  2021cites this paper
• An intact C-terminal end of albumin is required for its long half-life in humans

  2020cites this paper
• Prevalence of ABCC3‐1767G/A polymorphism among patients with antiretroviral‐associated hepatotoxicity

  2020influential citation
• Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients

  2020cites this paper
• miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells.

  2020cites this paper
• Ethnogeographic and inter-individual variability of human ABC transporters

  2020cites this paper
• Effect of Genetic Polymorphisms of Human SLC22A3 in the 5'-flanking Region on OCT3 Expression and Sebum Levels in Human Skin.

  2020cites this paper
• Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screens

  2020cites this paper
• CD markers polymorphisms as prognostic biomarkers in hematological malignancies

  2020cites this paper
• Laser-Responsive Polymeric Nanomicelles to Subdue Tumor Multidrug Resistance Based on Mild Photodynamic Therapy and Chemotherapy

  2020cites this paper
• Apoptosis and genes involved in oral cancer - a comprehensive review

  2020cites this paper
• MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer

  2020cites this paper
• Impact of gastrointestinal physiology on drug absorption in special populations - An UNGAP review.

  2020cites this paper
• The pharmacogenetics of opioid treatment for pain management

  2020cites this paper
• Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity

  2020cites this paper
• Effects of long-term feeding of rapeseed meal on skeletal muscle transcriptome, production efficiency and meat quality traits in Norwegian Landrace growing-finishing pigs

  2019cites this paper
• Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India

  2019cites this paper
• Simultaneous quantification of seven constituents from Zaoren Anshen prescription and four endogenic components in rat plasma by UHPLC-TSQ-MS/MS and the application of the correlation study.

  2019cites this paper
• Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.

  2019cites this paper
• Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation

  2019cites this paper
• Personalized medicine: going to the dogs?

  2019cites this paper
• Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population

  2019cites this paper
• Sample Preparation for LC‐MS Bioanalysis of Peripheral Blood Mononuclear Cells

  2019cites this paper
• Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets

  2019cites this paper
• Inter-individual Differences in the Expression of ABC and SLC Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 (MRP3) Gene

  2018cites this paper
• IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4

  2018cites this paper
• Drug Transporters as Therapeutic Targets: Computational Models, Challenges, and Future Perspective

  2018cites this paper
• Dynamic quantitative detection of ABC transporter family promoter methylation by MS-HRM for predicting MDR in pancreatic cancer

  2018cites this paper
• Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug–drug interaction profiles

  2018cites this paper
• An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus

  2018cites this paper
• Label Free Methods for the Quantification of Molecular Interaction with Membrane Protein on Cell Surface

  2018cites this paper
• Genotypes and haplotypes of ABCB1 contribute to TAC chemotherapy response in Malaysian triple negative breast cancer patients

  2018cites this paper
• Interindividual Differences in the Expression of ATP-Binding Cassette and Solute Carrier Family Transporters in Human Skin: DNA Methylation Regulates Transcriptional Activity of the Human ABCC3 Gene

  2018cites this paper
• Polymorphisms of ABCG2 and its impact on clinical relevance.

  2018cites this paper
• Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation

  2018cites this paper
• IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1)

  2018cites this paper
• Impact of Concomitantly Administered Curcumin on Pharmacokinetics of Daclatasvir in Mice Under the Frame of Herb-Drug Interaction

  2018cites this paper
• Intervention of curcumin on oral pharmacokinetics of daclatasvir in rat: A possible risk for long‐term use

  2018cites this paper
• SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer

  2018cites this paper
• Mutation of the gene encoding the circadian clock component PERIOD2 in oncogenic cells confers chemoresistance by up-regulating the Aldh3a1 gene

  2018cites this paper
• Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives

  2018influential citation
• Genetic and ethnic modulation of cardiovascular toxicity of vascular endothelial growth factor inhibitors

  2018cites this paper
• Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters

  2018cites this paper
• Effect of 5,7‐dimethoxyflavone on Bcrp1‐mediated transport of sorafenib in vitro and in vivo in mice

  2018cites this paper
• Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration

  2018cites this paper
• MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells

  2017cites this paper
• eUnaG: a new ligand-inducible fluorescent reporter to detect drug transporter activity in live cells

  2017cites this paper
• Association of Multi-Drug Resistance-1 (MDR1) Gene Polymorphism with Leukocytopenia in Breast Cancer Patients treated with Chemotherapy

  2017cites this paper
• Establishment of a cell line for assessing drugs as canine P‐glycoprotein substrates: proof of principle

  2017influential citation
• Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.

  2017cites this paper
• Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae

  2017cites this paper
• How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma.

  2017cites this paper
• Opioids Resistance in Chronic Pain Management

  2017cites this paper
• Evaluation of G 2677 T / A polymorphism of MDR 1 gene by polymerase chain reaction in Mazandaran province , Iran

  2017cites this paper